Citation Impact
Citing Papers
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Vitamin D Deficiency and Risk of Cardiovascular Disease
2008 Standout
Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney
2006 StandoutNobel
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis
2007
Prevention of Type 2 Diabetes Mellitus Through Inhibition of the Renin-Angiotensin System
2004
Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study
2009 Standout
Understanding Implementation: The Case of a Computerized Physician Order Entry System in a Large Dutch University Medical Center
2004
Identification and Importance of Brown Adipose Tissue in Adult Humans
2009 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis
2009 Standout
Recent hypertension trials
2005
Cellular senescence in aging and age-related disease: from mechanisms to therapy
2015 Standout
Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension
2010 Standout
Diabetes in treated hypertension is common and carries a high cardiovascular risk: results from a 28-year follow-up
2007
The metabolic syndrome
2010 Standout
Role of Computerized Physician Order Entry Systems in Facilitating Medication Errors
2005 Standout
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial
2005 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study
2017 Standout
Use of beta‐blockers in obesity hypertension: potential role of weight gain
2001
Antihypertensive treatment of patients with diabetes and hypertension
2001
Life’s Essential 8: Updating and Enhancing the American Heart Association’s Construct of Cardiovascular Health: A Presidential Advisory From the American Heart Association
2022 Standout
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials
2003
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
The metabolic syndrome
2005 Standout
Routine renin-angiotensin system blockade in renal transplantation?
2002
Why is hypertension so frequently uncontrolled in secondary prevention?
2003
The Kidney, Hypertension, and Remaining Challenges
2009
US Trends in Prevalence, Awareness, Treatment, and Control of Hypertension, 1988-2008
2010 Standout
New-onset diabetes and antihypertensive drugs
2005
Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
2002 Standout
Diabetes and Atherosclerosis
2002 Standout
Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT)
2000
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial
2003 Standout
Treatment of Hypertension in Patients 80 Years of Age or Older
2008 Standout
Insulin and insulin resistance:
2004 Standout
Hypertension in overweight and obese primary care patients is highly prevalent and poorly controlled
2004
Alzheimer's Disease
2010 Standout
Angiotensin II Type 1–Receptor Activating Antibodies in Renal-Allograft Rejection
2005 Standout
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial
2004 Standout
Efficacy of Indapamide SR Compared With Enalapril in Elderly Hypertensive Patients With Type 2 Diabetes
2006
Antihypertensive treatment in patients with type-2 diabetes mellitus
2002
Cardiovascular disease prevention with a multidrug regimen in the developing world: a cost-effectiveness analysis
2006
Physician Competencies for Prescribing Lifestyle Medicine
2010 Standout
Some Unintended Consequences of Information Technology in Health Care: The Nature of Patient Care Information System-related Errors
2003 Standout
Molecular Regulation of Vascular Smooth Muscle Cell Differentiation in Development and Disease
2004 Standout
The association of hypertension and diabetes: prevalence, cardiovascular risk and protection by blood pressure reduction
2005
Effect of Blood Pressure Lowering and Antihypertensive Drug Class on Progression of Hypertensive Kidney Disease<SUBTITLE>Results From the AASK Trial</SUBTITLE>
2002 Standout
Differential Impact of Blood Pressure–Lowering Drugs on Central Aortic Pressure and Clinical Outcomes
2006 Standout
Increasing incidence of abnormal glucose tolerance in women with prior abnormal glucose tolerance during pregnancy: DIAGEST 2 study
2007
Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004—BHS IV
2004
Increase in blood glucose concentration during antihypertensive treatment as a predictor of myocardial infarction: population based cohort study
2003
Outcomes With Nifedipine GITS or Co-Amilozide in Hypertensive Diabetics and Nondiabetics in Intervention as a Goal in Hypertension (INSIGHT)
2003
Strategies for enhancing the implementation of school-based policies or practices targeting risk factors for chronic disease
2017
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease
2003 Standout
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials
2003 Standout
Insulin Resistance and Cardiovascular Disease1
2001
Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss
2005 Standout
Preserving renal function in adults with hypertension and diabetes: A consensus approach
2000
AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update
2006 Standout
Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial
2010 Standout
Perceptions of Physician Order Entry: Results of a Cross-Site Qualitative Study
2003
Old antihypertensives and new diabetes
2004
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
2017 Standout
Acute Myocardial Infarction in Women
2016
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
Adverse Prognostic Significance of New Diabetes in Treated Hypertensive Subjects
2004
Metabolic and Clinical Outcomes in Nondiabetic Individuals With the Metabolic Syndrome Assigned to Chlorthalidone, Amlodipine, or Lisinopril as Initial Treatment for Hypertension
2008
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Mechanisms of Diabetic Complications
2013 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Hypothesis: β-Adrenergic Receptor Blockers and Weight Gain
2001
Cardiovascular Diseases in India
2016 Standout
Spontaneous coronary artery dissection
2017
Cardiac risk factors and the use of cardioprotective medications in patients with chronic renal insufficiency
2001
Diabetic Cardiomyopathy: Evidence, Mechanisms, and Therapeutic Implications
2004
Diabetes, Hypertension, and Cardiovascular Disease
2001
Recommendations for Blood Pressure Measurement in Humans and Experimental Animals
2005 Standout
Multiple Binding Modes of Inhibitors to Carbonic Anhydrases: How to Design Specific Drugs Targeting 15 Different Isoforms?
2012 Standout
Resistant Hypertension: Diagnosis, Evaluation, and Treatment
2008 Standout
Works of Todd Gress being referenced
Contrasting Views of Physicians and Nurses about an Inpatient Computer-based Provider Order-entry System
1999
Hypertension and Antihypertensive Therapy as Risk Factors for Type 2 Diabetes Mellitus
2000
Gender differences and predictors of mortality in spontaneous coronary artery dissection: a review of reported cases.
2005
Effects of a Brief Physical Activity Program on Young Students’ Physical Fitness
2015